Marieke G G Sturkenboom

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 15

Top Topics

Quality Control

Acinetobacter Baumannii

Top Venues

The Journal of antimicrobial chemotherapy

Antimicrobial agents and chemotherapy

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ralf Stemkens, Chaima Mouhdad, Eric J F Franssen, Daniel Touw, Jan Willem C Alffenaar, Lindsey H M Te Brake, Marieke G G Sturkenboom, Rob E Aarnoutse
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations. The Journal of antimicrobial chemotherapy 79 (6) (2024)
Ralf Stemkens, Chaima Mouhdad, Eric J F Franssen, Daniel Touw, Jan Willem C Alffenaar, Lindsey H M Te Brake, Marieke G G Sturkenboom, Rob E Aarnoutse
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations. The Journal of antimicrobial chemotherapy 79 (6) (2024)
Ralf Stemkens, Chaima Mouhdad, Eric J F Franssen, Daniel Touw, Jan Willem C Alffenaar, Lindsey H M Te Brake, Marieke G G Sturkenboom, Rob E Aarnoutse
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations. The Journal of antimicrobial chemotherapy (2024)
Ralf Stemkens, Chaima Mouhdad, Eric J F Franssen, Daniel Touw, Jan Willem C Alffenaar, Lindsey H M Te Brake, Marieke G G Sturkenboom, Rob E Aarnoutse
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations. The Journal of antimicrobial chemotherapy 79 (6) (2024)
Samiksha Ghimire, Gladys Molinas, Arturo Battaglia, Nilza Martinez, Luis Gómez Paciello, Sarita Aguirre, Jan Willem C Alffenaar, Marieke G G Sturkenboom, Cecile Magis-Escurra
Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study. Pharmaceutics 15 (4) (2023)
Lina Keutzer, Laurynas Mockeliunas, Marieke G G Sturkenboom, Mathieu S Bolhuis, Onno W Akkerman, Ulrika S H Simonsson
Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment. Pharmaceuticals (Basel, Switzerland) 16 (11) (2023)
Samiksha Ghimire, Gladys Molinas, Arturo Battaglia, Nilza Martinez, Luis Gómez Paciello, Sarita Aguirre, Jan Willem C Alffenaar, Marieke G G Sturkenboom, Cecile Magis-Escurra
Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study. Pharmaceutics 15 (4) (2023)
Samiksha Ghimire, Gladys Molinas, Arturo Battaglia, Nilza Martinez, Luis Gómez Paciello, Sarita Aguirre, Jan Willem C Alffenaar, Marieke G G Sturkenboom, Cecile Magis-Escurra
Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study. Pharmaceutics 15 (4) (2023)
Samiksha Ghimire, Gladys Molinas, Arturo Battaglia, Nilza Martinez, Luis Gómez Paciello, Sarita Aguirre, Jan Willem C Alffenaar, Marieke G G Sturkenboom, Cecile Magis-Escurra
Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study. Pharmaceutics 15 (4) (2023)
Juan Espinosa-Pereiro, Samiksha Ghimire, Marieke G G Sturkenboom, Jan Willem C Alffenaar, Margarida Tavares, Sarita Aguirre, Arturo Battaglia, Gladys Molinas, Teresa Tórtola, Onno W Akkerman, Adrian Sanchez-Montalva, Cecile Magis-Escurra
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial. Pharmaceutics 15 (1) (2022)
Reihaneh Abolhassani-Chimeh, Onno W Akkerman, Antonia M I Saktiawati, Nieko C Punt, Mathieu S Bolhuis, Yanri W Subronto, null Sumardi, Tjip S van der Werf, Jos G W Kosterink, Jan Willem C Alffenaar, Marieke G G Sturkenboom
Population Pharmacokinetic Modelling and Limited Sampling Strategies for Therapeutic Drug Monitoring of Pyrazinamide in Patients with Tuberculosis. Antimicrobial agents and chemotherapy 66 (7) (2022)
Laurynas Mockeliunas, Lina Keutzer, Marieke G G Sturkenboom, Mathieu S Bolhuis, Lotte M G Hulskotte, Onno W Akkerman, Ulrika S H Simonsson
Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis. Pharmaceutics 14 (4) (2022)
Juan Espinosa-Pereiro, Samiksha Ghimire, Marieke G G Sturkenboom, Jan Willem C Alffenaar, Margarida Tavares, Sarita Aguirre, Arturo Battaglia, Gladys Molinas, Teresa Tórtola, Onno W Akkerman, Adrian Sanchez-Montalva, Cecile Magis-Escurra
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial. Pharmaceutics 15 (1) (2022)
Juan Espinosa-Pereiro, Samiksha Ghimire, Marieke G G Sturkenboom, Jan Willem C Alffenaar, Margarida Tavares, Sarita Aguirre, Arturo Battaglia, Gladys Molinas, Teresa Tórtola, Onno W Akkerman, Adrian Sanchez-Montalva, Cecile Magis-Escurra
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial. Pharmaceutics 15 (1) (2022)
Juan Espinosa-Pereiro, Samiksha Ghimire, Marieke G G Sturkenboom, Jan Willem C Alffenaar, Margarida Tavares, Sarita Aguirre, Arturo Battaglia, Gladys Molinas, Teresa Tórtola, Onno W Akkerman, Adrian Sanchez-Montalva, Cecile Magis-Escurra
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial. Pharmaceutics 15 (1) (2022)